2003, Number 4
Rev Inst Nal Enf Resp Mex 2003; 16 (4)
Measurement of Quality of Life in Mexican Asthmatics.
Méndez-Guerra M, Salas-Hernández J, Vargas MH, Pérez-Chavira R, León-Munguía L, Franco-Martínez S, Chapela-Mendoza R
PDF size: 79.29 Kb.
Several studies have found derangement of the quality of life in asthmatic patients, but in Mexican patients this issue has not been addressed.
To assess the quality of life in patients with asthma of different severities.
A quality of life questionnaire (AQLQ) was applied to asthmatic outpatients attending the physician office of a third-level hospital devoted to respiratory diseases and located in Mexico City. This questionnaire has 32 items and measures four spheres (activity limitation, asthma symptoms, emotional function and environmental exposure).
The questionnaire was applied to 115 subjects (69% women), who had severe asthma in 32.2% of them, moderate asthma in 33.0% and mild asthma in 34.8%. The three groups were similar with respect to their sociodemographic features, tobacco habit or duration of the disease. We found no differences among groups in any of the spheres of the questionnaire, excepting in the emotional function, in which patients with severe asthma showed more derangement than patients with mild asthma (p‹0.05) or with moderate asthma (p‹0.01).
Patients with severe asthma have more deterioration in their emotional status than patients with milder forms of the disease. Ideally, the physician must identify these patients in order to offer them the proper psychological support.
Peat JK. The Epidemiology of Asthma. Curr Opin Pulm Med 1996;2:7-15.
Instituto Nacional de Enfermedades Respiratorias. Informe de Gobierno 2002. México: Secretaría de Salud, 2002.
Testa MA, Simonson DC. Assessment of Quality of Life Outcomes. N Engl J Med 1996;334:835-840.
Velarde-Jurado E, Ávila-Figueroa C. Evaluación de la calidad de vida. Salud Pública Méx 2002;44:342-361.
Smith TG. Introduction. In: Smith TG, editor. Measuring Health: a Practical Approach. London: John Wiley, 1988.
Velarde-Jurado E, Ávila-Figueroa C. Consideraciones metodológicas para evaluar la calidad de vida. Salud Pública Méx 2002;44:448-463.
Juniper FE, Gordon HG, Roberts SE, Ferrie PJ, Joeschke RK. Evaluation of Impairment of Health related Quality of Life in Asthma: Development of a Questionnaire for use in Clinical Trials. Thorax 1992;47:76-83.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. Bethesda: National Institutes of Health. National Heart, Lung and Blood Institute. Publication Number 95-3659. 1995. Revised 2002.
Gibson PG, Talbot PI, Toneguzzi RC. The Population Medicine Group. Self-management, Autonomy, and Quality of Life in Asthma. Chest 1995;107:1003-1008.
Patrick DL, Erickson P. What constitutes Quality of Life? Concepts and Dimensions. Clin Nutr 1988;7:53-63.
Patrick DL, Bergner M. Measurement of Health Status in the 1990s. Ann Rev Public Health 1990;11:165-183.
Shumacher M, Olschewsky M, Schulgen B. Assesment of Quality of Life in Clinical Trials. Statistics Med 1991;10:1.915-1.930.
Dales RE, Spitzer WO, Schechter MT, Suissa S. The influence of Psychological Status on Respiratory Symptom Reporting. Am Rev Respir Dis 1989;139: 1459-1463.
Rimington LD, Davies DH, Lowe D, Penson MG. Relation between Anxiety, Depression, and Morbidity in Adult Asthma Patients. Chest 1990: 97;628-634.
Hyland ME, Finnis S, Irvine SH. A Scale for Assesing Quality of Life in Adult Asthma Sufferers. J Psychosom Res 1991;35:99-110.
Katz PP, Eisner MD, Henke J, Shiboski S, Yelin EH, Blanc PD. The Marks Asthma Quality of Life Questionnaire: further Validation and Examination of Responsiveness to Change. J Clin Epidemiol 1999;52:667-675.
Goldfarb AA, Venutol F. The Use of an Antidepressant Drug in Chronically Allergic Individuals: a Double Blind Study. Ann Allergy 1963;21:667-676.
Janson C, Bjornsson E, Hetta J, Boman G. Anxiety and Depression in relation to Respiratory Symptoms and Asthma. Am J Respir Crit Care Med 1994;149: 930-934.
Sugihara H, Ishihara K, Noguchi H. Clinical Experience with Amitriptyline (tryptanol) in the Treatment of Bronchial Asthma. Ann Allergy 1965;23:422-429.
Meares RA, Mills JE, Horvath TB. Amitriptyline and Asthma. Med J Aust 1971;2:25-28.
Dudley DL, Sitzman J. Psychobiological Evaluation and Treatment of Chronic Obstructive Pulmonary Disease. In: Mo AJ, Grant I, editors. Chronic Obstructive Pulmonary Disease, Behavioural perspective. New York: Dekker, 1988:183-185.
Yellowlees PM, Kalucy RS. Psychobiological Aspects of Asthma and the Consequent Research Implications. Chest 1990;97:628-634.
Hibbert G, Pilsbury D. Demonstration and Treatment of Hyperventilation causing Asthma. Br J Psychiatry 1988;153:687-688.
Bass C, Graduer WN. Respiratory and Psychiatric Abnormalities in Chronic Symptomatic Hyperventilation. Br Med J 1985;290:1387-1390.